secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition Corp. (DMAA)
CIK:        0002028614
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024762
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Drugs Made In America confirms trust account intact after affiliate irregularities
--------------------------------------------------------------------------------

- Sponsor made improper withdrawals from affiliate's working capital account between Sept 26, 2025 and Dec 31, 2025.
- Board immediately acted; irregularities did not extend to the company's trust account.
- As of March 6, 2026, trust account holds approximately $241,292,436.
- No details on amount of irregularity or actions against sponsor disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2028614/000121390026024762/0001213900-26-024762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2028614/000121390026024762/ea028047001-8k_drugscorp.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer